首頁 > 市場調查報告書 > 醫療設備

眼科設備

市場調查報告書

商品編碼

1486843

全球眼壓計市場：洞察、競爭格局、市場預測：2030 年

Tonometers - Market Insights, Competitive Landscape and Market Forecast-2030

出版日期: 2024年05月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

2023年全球眼壓計市場規模為3.3929億美元。預計到 2030 年，該市場將達到 5.5566 億美元，2024 年至 2030 年的預測期內複合年增長率為 6.06%。眼壓計的需求主要是由青光眼、高眼壓症、開角型青光眼、葡萄膜炎、角膜疾病、白內障手術以及易患青光眼的糖尿病人群等眼科疾病發病率的上升所推動的。此外，由於準確性、易用性和患者舒適度等眾多技術進步，眼壓計市場預計將在全球範圍內增長。這些是2024年至2030年預測期內眼壓計市場積極成長的關鍵因素。

預計 2022 年，7 個主要國家的青光眼診斷人數將接近 7,045,443 人）；這些數據和統計數據預計將推動全球眼壓計的整體未來市場。

根據歐盟委員會（2023）的數據，2021年白內障手術是歐盟（EU）的主流，歐盟國家共進行了432萬例手術。此外，根據同一份文件，2021年法國每10萬人白內障手術率最高，為每10萬人1,417例手術，其次是奧地利（每10萬人1,340例手術）。此外，根據國際防盲機構（IAPB）在2020年進行的一項研究，全球患有中度至重度白內障的人口為83,475,182人。眼壓計用於白內障手術的術前和術後評估，以評估和管理眼內壓（IOP）的變化，因此這些數據和統計數據將推動全球眼壓計的整體未來市場。

本報告研究了全球眼壓計市場，並提供了市場概況，包括依設備類型、移動性、最終用戶、地區和參與市場的公司概況劃分的趨勢。

Halma Plc
HAAG-STREIT AG
Topcon Corporation
NIDEK CO., LTD
Reichert, Inc.
Keeler.
OCULUS Optikgerate GmbH
Tomey USA
CANON MEDICAL SYSTEMS USA, Inc.
Kowa Company, Ltd.,
Reichert, Inc.
AMETEK, Inc.
NIDEK CO., Ltd.
Accutome Inc.
Keeler.
Itamar Medical Ltd.
Shenzhen Mindray Bio-Medical Electronics Co Ltd.
Millar
DAEYOMEDI
Alam Medical

第9章KOL瀏覽量

第 10 章專案方法

第 11 章關於 DelveInsight

第 12 章免責聲明與聯絡我們

簡介目錄圖表

Product Code: DIMDCL0133

Tonometer Market By Device Types (Applanation {Goldman Tonometer, Perkins Applanation Tonometer, And Others}, Indentation Tonometers, Non- Contact Tonometer, Rebound Tonometer, Dynamic Contour Tonometer), Portability (Desktop Tonometer, Hand-Held Tonometer), End- User (Hospitals, Opthalmic Clinic, And Others), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady cagr forecast till 2030 owing to the rising prevelance of opthalmic disorders such as glaucoma, ocular hypertension, uveitis, corneal disorders, cataract surgery, and technological advancement across the globe.

The global Tonometer market was valued at USD 339.29 million in 2023, growing at a CAGR of 6.06% during the forecast period from 2024 to 2030 to reach USD 505.66 million by 2030. The demand for tonometers is primarily being boosted by the growing incidence of ophthalmic disorders such as glaucoma, ocular hypertension, open-angle glaucoma, uveitis, corneal disorders, cataract surgery, and the diabetic population who are more prone to glaucoma. Furthermore, the tonometer market is anticipated to grow on account of a large number of technological advancements such as improved accuracy, ease of use, and patient comfort across the globe. These are the major drivers that are responsible for contributing to the positive growth of the tonometer market during the forecast period from 2024-2030.

Tonometer Market Dynamics:

According, to the estimates of DelveInsight the total glaucoma diagnosed prevalent cases were estimated at nearly 7,045,443 cases in 2022 in the 7MM, however the overall burden of glaucoma has been estimated to be nearly 16,632,421 (Prevalent cases) in 2022 in the 7MM. Hence, these data and stats are accepted to fuel the overall future market of tonometers across the globe as glaucoma is a progressive eye disease characterized by damage to the optic nerve, often associated with elevated intraocular pressure (IOP) and requires a tonometer for monitoring and diagnosing the conditions.

According to the European Commission (2023), in 2021, the European Union saw cataract surgery as the predominant surgical procedure, with a significant 4.32 million operations performed across EU nations. Additionally, as per the same source France had the highest rate of cataract surgery per 100,000 population in 2021 estimating 1,417 per 100,000 population followed by Austria (1,340 PER 100,000 population). Furthermore, as per the study conducted by the International Agency for the Prevention of Blindness (IAPB) in 2020, the global population affected by moderate to severe cataracts was 83,475,182. These data and stats are accepted to fuel the overall future market of tonometer across the globe as tonometers are used during pre-operative and post-operative assessment of cataract surgery to assess and manage the changes in Intraocular pressure (IOP).

Furthermore, tonometers can be used as part of the overall assessment of diabetic eye disease and its complications. Additionally, as per the study conducted by the International Agency for the Prevention of Blindness (IAPB) in 2020, the global population affected by moderate to severe diabetic retinopathy was 3,278,034. Diabetic retinopathy is a complication of diabetes affecting the eyes and needs regular eye checkups including IOP measurements. Hence, the prevalence and incidence rates of ocular diseases such as glaucoma, cataract surgery, and diabetes retinopathy highlight the future significant market growth of tonometer.

Further, the continuous advancements in tonometry technology are driving the overall market of tonometers. In November 2022, NIDEK has introduced the NT-1p non-contact Tono/Pachymeter, an innovative device designed to automate both reliable non-contact tonometry and pachymetry. This advanced technology automatically detects the position of the eyes, initiating measurements without the need for manual button presses. This streamlined approach enhances efficiency and user experience, making the device particularly convenient for eye care professionals conducting intraocular pressure and corneal thickness assessments. Additionally, the growing awareness about the importance of regular eye check-ups and early detection of eye diseases is also contributing to fueling the current demand for tonometers.

However, the risk of infection with contact tonometers and lack of accuracy in non-contact tonometers during checkups may hinder the market demand for tonometers.

Tonometer Market Segment Analysis:

Tonometer Market by Device Types (Applanation {Goldman Tonometer, Perkins Applanation Tonometer, and Others}), Indentation Tonometers, Non-Contact Tonometer, Rebound Tonometer, Dynamic Contour Tonometer), Portability (Desktop Tonometer, Hand-Held Tonometer), End-User (Hospitals, Ophthalmic Clinic, And Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product segment of the tonometer market, the applanation tonometer category is estimated to have a significant revenue share in the tonometer market in 2023. This can be attributed to the various advantages and applications provided by the applanation tonometer. These devices are used to measure the intraocular pressure (IOP) by flattening a small area of the cornea and are considered one of the most accurate methods of measuring IOP. Applanation tonometers with non-contact options offer similar accuracy to contact tonometers. Some applanation tonometers, such as the Goldman tonometer, can be used in a non-contact mode, reducing the risk of corneal abrasions or infections associated with contact methods. Besides this, the absence of the need for fluorescein dye instillation or tropical anesthesia during tonometer use simplifies the procedure and enhances safety. All these advanced features of applanation tonometer are promoting the growth of overall tonometers. Applanation tonometers provide a direct measurement of IOP by directly assessing the cornea's response to pressure. Thus resulting in a more objective and accurate measurement of intraocular pressure.

Hence, the applanation tonometer is regarded as the gold standard for measuring IOP, and it's user-friendly and relatively easy operation, requiring minimal training for healthcare professionals will contribute to the growth of the overall tonometer market during the forecast period.

North America Is Expected To Dominate The Overall Tonometer Market:

North America is expected to account for the highest proportion of the global tonometer market in 2023, out of all regions. This is due to the presence of a large patient pool suffering from an ophthalmic disorder such as glaucoma, ocular hypertension, open angle glaucoma, uveitis, corneal disorders, cataract surgery, diabetic population who are more prone to glaucoma, and technological advancement.

According to the data provided by the Centers for Disease Control and Prevention (CDC) (2023), in 2021, in the United States, among people with diabetes, the prevalence rate of diabetes retinopathy was lowest among people younger than age 25 at 13.0% and highest among the 65-79 age group at 28.4%. Thus tonometer can be used to monitor IOP regularly in diabetic patients to detect any potential changes in IOP that may indicate the presence of glaucoma alongside diabetic retinopathy.

According to the latest data provided by the Centers for Disease Control and Prevention (CDC) (2020), glaucoma affects approximately 3 million Americans and ranks as the second leading cause of blindness globally. As per the same source, the number of glaucoma patients is expected to rise to 6.3 million by 2050 in America. The open-angle glaucoma, the predominant form is characterized by elevated eye pressure, often occurring without early symptoms and leaving 50% of affected individuals unaware of their condition. As a result, these statistics and data are expected to fuel the future market of tonometer devices in North America as intraocular pressure (IOP) monitoring is important in ocular disease to assess and manage the changes in IOP.

Furthermore, recent strategic initiatives and various product approvals of tonometers are also aiding in driving the market growth of tonometer devices in the region. In March 2022, Icare attained 510(k) clearance from the FDA in the United States for their latest self-tonometer iteration, the iCare HOME2. This innovative device is designed to simplify the process of measuring patients' intraocular pressure (IOP) beyond regular clinic hours, aiming to aid in the management of glaucoma. Thus the new product approval with advanced technologies is driving the market growth of tonometer in North America.

Additionally, the increase in the rising awareness programs by government authorities are also facilitating the overall use of tonometers thus increasing the future market of tonometer in the United States. Several government authorities in America such as the National Eye Health Education Program (NEHEP), in coordination with the National Eye Institute (NEI) of the National Institutes of Health (NIH) promotes eye health awareness across the United States like Glaucoma Awareness Month. Thus, the increased eye care awareness programs are contributing to market growth of tonometer In North America.

Tonometer Market Key Players:

Some of the key market players operating in the Tonometer include Ziemer Ophthalmic Systems AG, Haag- streit, Topcon Corporation, NIDEK CO., LTD, Reichert, Inc., Keeler., OCULUS Optikgerate GmbH, Tomey USA, Canon medical systems USA, Inc., Kowa Company, Ltd., Reichert, Inc., Ametek, Inc., Nidek CO., Ltd., Accutome Inc., Keeler., Itamar Medical Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd., Millar, DAEYOMEDI, Alam Medical.

Recent Developmental Activities In The Tonometer Market:

In May 2023 marked the launch of the Tono-Vera(R) Tonometer by Reichert Technologies, a subsidiary of AMETEK, Inc. This handheld tonometer, equipped with the ActiView(TM) Positioning System, stands out for its ability to deliver fast and dependable measurements of intraocular pressure, reinforcing Reichert's reputation as a global leader in eye care diagnostic devices.

Key Takeaways From The Tonometer Market Report Study

Market size analysis for current Tonometer Market size (2023), and market forecast for 6 years (2024-2030)
Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the global Tonometer market.
Various opportunities available for the other competitors in the Tonometer Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current Tonometer market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Tonometer market growth in the coming future?

Target Audience Who Can Be Benefited From This Tonometer Market Report Study

Tonometer product providers
Research organizations and consulting companies
Cardiac Restoration Systems-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in Tonometer
Various end-users who want to know more about the Tonometer Market and the latest technological developments in the Tonometer Market.

Frequently Asked Questions For The Tonometer Market:

1. What are Tonometer?

A tonometer is a medical device used to measure the intraocular pressure (IOP) within the eye. Intraocular pressure refers to the fluid pressure inside the eye, which is primarily determined by the balance between the production and drainage of aqueous humor, the clear fluid that fills the anterior chamber of the eye.

2. What is the market for Tonometer?

The global Tonometer market was valued at USD 339.29 million in 2023, growing at a CAGR of 6.06% during the forecast period from 2024 to 2030 to reach USD 505.66 million by 2030.

3. What are the drivers for the global Tonometer market?

The demand for tonometers is primarily being boosted by the growing incidence of ophthalmic disorders such as glaucoma, ocular hypertension, open angle glaucoma, uveitis, corneal disorders, cataract surgery, and diabetic population who are more prone to glaucoma. Furthermore, the tonometer market is anticipated to grow on account of a large number of technological advancements such as improved accuracy, ease of use, and patient comfort across the globe. These are the major drivers that are responsible for contributing to the positive growth of the Tonometer market during the forecast period from 2024-2030.

4. Who are the key players operating in the global Tonometer market?

Some of the key market players operating in the Tonometer included Halma Plc, Haag- streit, Topcon Corporation, Nidek Co., Ltd, Reichert, Inc., Keeler., Oculus Optikgerate GmbH, Tomey USA, Canon medical systems USA, Inc., Kowa Company, Ltd., Reichert, Inc., Ametek, Inc., Nidek Co., Ltd., Accutome Inc., Keeler., Itamar Medical Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd., Millar, Daeyomedi, Alam Medical.

5. Which region has the highest share in the global Tonometer market?

North America is expected to account for the highest proportion of the tonometer Market in 2023, out of all regions. This is due to the presence of a large patient pool suffering from an ophthalmic disorder such as glaucoma, ocular hypertension, open angle glaucoma, uveitis, corneal disorders, cataract surgery, diabetic population who are more prone to glaucoma, and technological advancement in tonometers are some other major factors that are responsible in contributing to the positive growth of the tonometer market in North America.

1. Tonometer Market Report Introduction

1.1. Scope of the Study
1.2. Market Segmentation
1.3. Market Assumption

2. Tonometer Market Executive Summary

2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

4.1. The United States
4.2. Europe
4.3. Japan
4.4. China

5. Tonometer Market Key Factors Analysis

5.1. Tonometer Market Drivers
- 5.1.1. Rising prevalence of ophthalmic disorders such as glaucoma and others
- 5.1.2. Innovation in technology
- 5.1.3. Increasing awareness and screening programs
5.2. Tonometer Market Restraints and Challenges
- 5.2.1. Risk of infection in contact tonometers.
- 5.2.2. Lack of accuracy in non-contact tonometers.
5.3. Tonometer Market Opportunities
- 5.3.1. Ongoing advancements in tonometry technology.

6. Tonometer Market Porter's Five Forces Analysis

6.1. Bargaining Power of Suppliers
6.2. Bargaining Power of Consumers
6.3. Threat of New Entrants
6.4. Threat of Substitutes
6.5. Competitive Rivalry

7. Tonometer Market Assessment

7.1. By Device Type
- 7.1.1. Applanation Tonometer
  - 7.1.1.1. Goldman Tonometer
  - 7.1.1.2. Perkins Applanation Tonometer
  - 7.1.1.3. Others
- 7.1.2. Indentation Tonometers
- 7.1.3. Non-Contact Tonometer
- 7.1.4. Rebound Tonometer
- 7.1.5. Dynamic Contour Tonometer
7.2. By Mobility
- 7.2.1. Desktop Tonometer
- 7.2.2. Hand-Held Tonometer
7.3. By End-User
- 7.3.1. Hospitals
- 7.3.2. Ophthalmic Clinics
- 7.3.3. Others
7.4. By Geography
- 7.4.1. North America
  - 7.4.1.1. United States Tonometer Market Size in USD million (2021-2030)
  - 7.4.1.2. Canada Tonometer Market Size in USD million (2021-2030)
  - 7.4.1.3. Mexico Tonometer Market Size in USD million (2021-2030)
- 7.4.2. Europe
  - 7.4.2.1. France Tonometer Market Size in USD million (2021-2030)
  - 7.4.2.2. Germany Tonometer Market Size in USD million (2021-2030)
  - 7.4.2.3. United Kingdom Tonometer Market Size in USD million (2021-2030)
  - 7.4.2.4. Italy Tonometer Market Size in USD million (2021-2030)
  - 7.4.2.5. Spain Tonometer Market Size in USD million (2021-2030)
  - 7.4.2.6. Rest of Europe Tonometer Market Size in USD million (2021-2030)
- 7.4.3. Asia-Pacific
  - 7.4.3.1. China Tonometer Market Size in USD million (2021-2030)
  - 7.4.3.2. Japan Tonometer Market Size in USD million (2021-2030)
  - 7.4.3.3. India Tonometer Market Size in USD million (2021-2030)
  - 7.4.3.4. Australia Tonometer Market Size in USD million (2021-2030)
  - 7.4.3.5. South Korea Tonometer Market Size in USD million (2021-2030)
  - 7.4.3.6. Rest of Asia-Pacific Tonometer Market Size in USD million (2021-2030)
- 7.4.4. Rest of the World (RoW)
  - 7.4.4.1. Middle East Tonometer Market Size in USD million (2021-2030)
  - 7.4.4.2. Africa Tonometer Market Size in USD million (2021-2030)
  - 7.4.4.3. South America Tonometer Market Size in USD million (2021-2030)

8. Tonometer Market Company and Product Profiles

8.1. Halma Plc
- 8.1.1. Company Overview
- 8.1.2. Company Snapshot
- 8.1.3. Financial Overview
- 8.1.4. Product Listing
- 8.1.5. Entropy
8.2. HAAG-STREIT AG
- 8.2.1. Company Overview
- 8.2.2. Company Snapshot
- 8.2.3. Financial Overview
- 8.2.4. Product Listing
- 8.2.5. Entropy
8.3. Topcon Corporation
- 8.3.1. Company Overview
- 8.3.2. Company Snapshot
- 8.3.3. Financial Overview
- 8.3.4. Product Listing
- 8.3.5. Entropy
8.4. NIDEK CO., LTD
- 8.4.1. Company Overview
- 8.4.2. Company Snapshot
- 8.4.3. Financial Overview
- 8.4.4. Product Listing
- 8.4.5. Entropy
8.5. Reichert, Inc.
- 8.5.1. Company Overview
- 8.5.2. Company Snapshot
- 8.5.3. Financial Overview
- 8.5.4. Product Listing
- 8.5.5. Entropy
8.6. Keeler.
- 8.6.1. Company Overview
- 8.6.2. Company Snapshot
- 8.6.3. Financial Overview
- 8.6.4. Product Listing
- 8.6.5. Entropy
8.7. OCULUS Optikgerate GmbH
- 8.7.1. Company Overview
- 8.7.2. Company Snapshot
- 8.7.3. Financial Overview
- 8.7.4. Product Listing
- 8.7.5. Entropy
8.8. Tomey USA
- 8.8.1. Company Overview
- 8.8.2. Company Snapshot
- 8.8.3. Financial Overview
- 8.8.4. Product Listing
- 8.8.5. Entropy
8.9. CANON MEDICAL SYSTEMS USA, Inc.
- 8.9.1. Company Overview
- 8.9.2. Company Snapshot
- 8.9.3. Financial Overview
- 8.9.4. Product Listing
- 8.9.5. Entropy
8.10. Kowa Company, Ltd.,
- 8.10.1. Company Overview
- 8.10.2. Company Snapshot
- 8.10.3. Financial Overview
- 8.10.4. Product Listing
- 8.10.5. Entropy
8.11. Reichert, Inc.
- 8.11.1. Company Overview
- 8.11.2. Company Snapshot
- 8.11.3. Financial Overview
- 8.11.4. Product Listing
- 8.11.5. Entropy
8.12. AMETEK, Inc.
- 8.12.1. Company Overview
- 8.12.2. Company Snapshot
- 8.12.3. Financial Overview
- 8.12.4. Product Listing
- 8.12.5. Entropy
8.13. NIDEK CO., Ltd.
- 8.13.1. Company Overview
- 8.13.2. Company Snapshot
- 8.13.3. Financial Overview
- 8.13.4. Product Listing
- 8.13.5. Entropy
8.14. Accutome Inc.
- 8.14.1. Company Overview
- 8.14.2. Company Snapshot
- 8.14.3. Financial Overview
- 8.14.4. Product Listing
- 8.14.5. Entropy
8.15. Keeler.
- 8.15.1. Company Overview
- 8.15.2. Company Snapshot
- 8.15.3. Financial Overview
- 8.15.4. Product Listing
- 8.15.5. Entropy
8.16. Itamar Medical Ltd.
- 8.16.1. Company Overview
- 8.16.2. Company Snapshot
- 8.16.3. Financial Overview
- 8.16.4. Product Listing
- 8.16.5. Entropy
8.17. Shenzhen Mindray Bio-Medical Electronics Co Ltd.
- 8.17.1. Company Overview
- 8.17.2. Company Snapshot
- 8.17.3. Financial Overview
- 8.17.4. Product Listing
- 8.17.5. Entropy
8.18. Millar
- 8.18.1. Company Overview
- 8.18.2. Company Snapshot
- 8.18.3. Financial Overview
- 8.18.4. Product Listing
- 8.18.5. Entropy
8.19. DAEYOMEDI
- 8.19.1. Company Overview
- 8.19.2. Company Snapshot
- 8.19.3. Financial Overview
- 8.19.4. Product Listing
- 8.19.5. Entropy
8.20. Alam Medical
- 8.20.1. Company Overview
- 8.20.2. Company Snapshot
- 8.20.3. Financial Overview
- 8.20.4. Product Listing
- 8.20.5. Entropy